Compare Nippon Shinyaku Co., Ltd. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
JPY 282,341 Million (Small Cap)
9.00
NA
0.00%
-0.27
10.20%
0.97
Revenue and Profits:
Net Sales:
49,066 Million
(Quarterly Results - Jun 2026)
Net Profit:
10,108 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.14%
0%
-12.14%
6 Months
-30.28%
0%
-30.28%
1 Year
9.3%
0%
9.3%
2 Years
11.09%
0%
11.09%
3 Years
-39.76%
0%
-39.76%
4 Years
-54.48%
0%
-54.48%
5 Years
-57.04%
0%
-57.04%
Nippon Shinyaku Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.65%
EBIT Growth (5y)
6.12%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
0.64
Tax Ratio
18.47%
Dividend Payout Ratio
28.12%
Pledged Shares
0
Institutional Holding
3.50%
ROCE (avg)
20.82%
ROE (avg)
12.48%
Valuation key factors
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
0.99
EV to EBIT
6.16
EV to EBITDA
5.23
EV to Capital Employed
0.98
EV to Sales
1.33
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
15.96%
ROE (Latest)
10.52%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot : Mar 2015
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 0 Foreign Institutions (0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
49,066.00
43,636.00
12.44%
Operating Profit (PBDIT) excl Other Income
12,844.00
4,386.00
192.84%
Interest
41.00
46.00
-10.87%
Exceptional Items
0.00
0.00
Consolidate Net Profit
10,108.00
3,878.00
160.65%
Operating Profit Margin (Excl OI)
225.60%
60.60%
16.50%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 12.44% vs -8.11% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is 160.65% vs -61.56% in Mar 2026
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
170,771.00
160,232.00
6.58%
Operating Profit (PBDIT) excl Other Income
39,662.00
42,779.00
-7.29%
Interest
119.00
102.00
16.67%
Exceptional Items
-47.00
-892.00
94.73%
Consolidate Net Profit
29,728.00
32,560.00
-8.70%
Operating Profit Margin (Excl OI)
193.40%
229.40%
-3.60%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 6.58% vs 8.08% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is -8.70% vs 25.94% in Mar 2025
About Nippon Shinyaku Co., Ltd. 
Nippon Shinyaku Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






